:SARS-CoV-2

Amy Papaneri1, Guohong Cui1, Shih-Heng Chen2

  • 1In Vivo Neurobiology Group, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC 27709, USA.

Microorganisms
|August 28, 2025
PubMed
概括

新一代的分子诊断技术,如CRISPR和生物传感器, 可以更快,更灵敏地检测病原体. 本次审查分析了它们的战略和经济可行性,以应对未来的流行病,并强调了节省成本的好处.